Non-sleep effects of hypocretin/orexin

被引:55
|
作者
Samson, WK
Taylor, MM
Ferguson, AV
机构
[1] St Louis Univ, Sch Med, St Louis, MO 63104 USA
[2] Queens Univ, Kingston, ON K7L 3N6, Canada
关键词
neuroendocrine; autonomic nervous system; stress; reproduction; aminergic neurotransmitters; appetite; neuropeptide Y; corticotropin releasing factor;
D O I
10.1016/j.smrv.2004.07.006
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Although a role for hypocretin/orexin (HCT/ORX) in sleep/wakefulness and arousal is widely recognized, other actions, not necessarily related to sleep, have been identified. Neurons producing the peptides project to brain sites known to be important in neuroendocrine and autonomic function, as well as appetite regulation. There is consensus that HCT/ORX plays a role in the regulation of cardiovascular function via its effects on sympathetic nervous activity, and the reported pharmacologic effects have been demonstrated to be physiologically relevant. Equally provocative are the actions of these peptides in the hypothalamus and pituitary gland to regulate reproductive and stress hormone secretion. While HCT/ORX are less potent stimulators of food intake than other hypothalamic peptides, HCT/ORX may play an integral role in the organization of hunger and satiation behaviors because of their interaction with those other peptides. In fact recent discoveries of interactions of HCT/ORX with peptides such as corticotropin releasing hormone and neuropeptide Y, as well as with aminergic neurotransmitter systems, are now defining the cellular and molecular mechanisms by which these potent neuropeptides act and promise insight into their physiologic relevance in a variety of non-steep related behaviors and other homeostatic mechanisms. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:243 / 252
页数:10
相关论文
共 50 条
  • [1] Sleep, sleep disorders and hypocretin (orexin)
    Mignot, E
    [J]. SLEEP MEDICINE, 2004, 5 : S2 - S8
  • [2] Hypocretin/orexin, sleep and narcolepsy
    Hungs, M
    Mignot, E
    [J]. BIOESSAYS, 2001, 23 (05) : 397 - 408
  • [3] Hypocretin (orexin) pathway to sleep
    George, CFP
    Singh, SM
    [J]. LANCET, 2000, 355 (9197): : 6 - 6
  • [4] Hypocretin/orexin effects on cardiovascular regulation during sleep
    schwimmer H.
    Zeitzer, J. M.
    Masashi, Y.
    Nishino, S.
    Shengwen, Z.
    Mignot, E.
    [J]. SLEEP, 2006, 29 : A31 - A31
  • [5] Hypocretin/orexin in sleep and mood disorders
    Fabre, V.
    Rachalski, A.
    Bernard, J. F.
    Lin, J. S.
    Hamon, M.
    Vodjdani, G.
    Adrien, J.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2012, 22 : S145 - S146
  • [6] Effects of intranasal hypocretin-1 (orexin A) on sleep in narcolepsy with cataplexy
    Baier, P. C.
    Hallschmid, M.
    Seeck-Hirschner, M.
    Weinhold, S. L.
    Burkert, S.
    Diessner, N.
    Goeder, R.
    Aldenhoff, J. B.
    Hinze-Selch, D.
    [J]. SLEEP MEDICINE, 2011, 12 (10) : 941 - 946
  • [7] Non-Sleep Electroencephalogram Activation
    Weil, Andre A.
    [J]. DISEASES OF THE NERVOUS SYSTEM, 1952, 13 (01): : 11 - 16
  • [8] A decade of hypocretin/orexin: Accomplishments in sleep medicine
    Thannickal, Thomas Chacko
    [J]. SLEEP MEDICINE REVIEWS, 2009, 13 (01) : 5 - 8
  • [9] The Hypocretin/Orexin neuropeptides in sleep and psychiatric disorders
    Ebrahim, I
    [J]. SOUTH AFRICAN JOURNAL OF PSYCHIATRY, 2007, 13 (01) : 28 - 28
  • [10] Hypocretin (orexin) in neurological, sleep and psychiatric disorders: A prospective study of CSF hypocretin
    Ebrahim, IO
    Howard, RS
    Williams, AJ
    de Lacy, S
    Semra, Y
    Kopelman, MD
    Sharief, MK
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2003, 74 (03): : 406 - 406